Adamantane-Substituted Purines and Their β-Cyclodextrin Complexes: Synthesis and Biological Activity

Cyclin-dependent kinases (CDKs) play an important role in the cell-division cycle. Synthetic inhibitors of CDKs are based on 2,6,9-trisubstituted purines and are developed as potential anticancer drugs; however, they have low solubility in water. In this study, we proved that the pharmaco-chemical p...

Full description

Bibliographic Details
Main Authors: Michal Rouchal, Jana Rudolfová, Vladimír Kryštof, Veronika Vojáčková, Richard Čmelík, Robert Vícha
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/23/12675
_version_ 1797507806981521408
author Michal Rouchal
Jana Rudolfová
Vladimír Kryštof
Veronika Vojáčková
Richard Čmelík
Robert Vícha
author_facet Michal Rouchal
Jana Rudolfová
Vladimír Kryštof
Veronika Vojáčková
Richard Čmelík
Robert Vícha
author_sort Michal Rouchal
collection DOAJ
description Cyclin-dependent kinases (CDKs) play an important role in the cell-division cycle. Synthetic inhibitors of CDKs are based on 2,6,9-trisubstituted purines and are developed as potential anticancer drugs; however, they have low solubility in water. In this study, we proved that the pharmaco-chemical properties of purine-based inhibitors can be improved by appropriate substitution with the adamantane moiety. We prepared ten new purine derivatives with adamantane skeletons that were linked at position 6 using phenylene spacers of variable geometry and polarity. We demonstrated that the adamantane skeleton does not compromise the biological activity, and some of the new purines displayed even higher inhibition activity towards CDK2/cyclin E than the parental compounds. These findings were supported by a docking study, which showed an adamantane scaffold inside the binding pocket participating in the complex stabilisation with non-polar interactions. In addition, we demonstrated that β-cyclodextrin (CD) increases the drug’s solubility in water, although this is at the cost of reducing the biochemical and cellular effect. Most likely, the drug concentration, which is necessary for target engagement, was decreased by competitive drug binding within the complex with β-CD.
first_indexed 2024-03-10T04:53:37Z
format Article
id doaj.art-c111a4005877411e891420cb63a64840
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T04:53:37Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-c111a4005877411e891420cb63a648402023-11-23T02:26:15ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-11-0122231267510.3390/ijms222312675Adamantane-Substituted Purines and Their β-Cyclodextrin Complexes: Synthesis and Biological ActivityMichal Rouchal0Jana Rudolfová1Vladimír Kryštof2Veronika Vojáčková3Richard Čmelík4Robert Vícha5Department of Chemistry, Faculty of Technology, Tomas Bata University in Zlín, Vavrečkova 275, 760 01 Zlín, Czech RepublicDepartment of Chemistry, Faculty of Technology, Tomas Bata University in Zlín, Vavrečkova 275, 760 01 Zlín, Czech RepublicDepartment of Experimental Biology, Palacký University, Šlechtitelů 27, 783 71 Olomouc, Czech RepublicDepartment of Experimental Biology, Palacký University, Šlechtitelů 27, 783 71 Olomouc, Czech RepublicInstitute of Analytical Chemistry of the Czech Academy of Sciences, Veveří 97, 602 00 Brno, Czech RepublicDepartment of Chemistry, Faculty of Technology, Tomas Bata University in Zlín, Vavrečkova 275, 760 01 Zlín, Czech RepublicCyclin-dependent kinases (CDKs) play an important role in the cell-division cycle. Synthetic inhibitors of CDKs are based on 2,6,9-trisubstituted purines and are developed as potential anticancer drugs; however, they have low solubility in water. In this study, we proved that the pharmaco-chemical properties of purine-based inhibitors can be improved by appropriate substitution with the adamantane moiety. We prepared ten new purine derivatives with adamantane skeletons that were linked at position 6 using phenylene spacers of variable geometry and polarity. We demonstrated that the adamantane skeleton does not compromise the biological activity, and some of the new purines displayed even higher inhibition activity towards CDK2/cyclin E than the parental compounds. These findings were supported by a docking study, which showed an adamantane scaffold inside the binding pocket participating in the complex stabilisation with non-polar interactions. In addition, we demonstrated that β-cyclodextrin (CD) increases the drug’s solubility in water, although this is at the cost of reducing the biochemical and cellular effect. Most likely, the drug concentration, which is necessary for target engagement, was decreased by competitive drug binding within the complex with β-CD.https://www.mdpi.com/1422-0067/22/23/12675adamantane2,6,9-trisubstituted purinecyclin-dependent kinasecytotoxicityβ-cyclodextrinmolecular docking
spellingShingle Michal Rouchal
Jana Rudolfová
Vladimír Kryštof
Veronika Vojáčková
Richard Čmelík
Robert Vícha
Adamantane-Substituted Purines and Their β-Cyclodextrin Complexes: Synthesis and Biological Activity
International Journal of Molecular Sciences
adamantane
2,6,9-trisubstituted purine
cyclin-dependent kinase
cytotoxicity
β-cyclodextrin
molecular docking
title Adamantane-Substituted Purines and Their β-Cyclodextrin Complexes: Synthesis and Biological Activity
title_full Adamantane-Substituted Purines and Their β-Cyclodextrin Complexes: Synthesis and Biological Activity
title_fullStr Adamantane-Substituted Purines and Their β-Cyclodextrin Complexes: Synthesis and Biological Activity
title_full_unstemmed Adamantane-Substituted Purines and Their β-Cyclodextrin Complexes: Synthesis and Biological Activity
title_short Adamantane-Substituted Purines and Their β-Cyclodextrin Complexes: Synthesis and Biological Activity
title_sort adamantane substituted purines and their β cyclodextrin complexes synthesis and biological activity
topic adamantane
2,6,9-trisubstituted purine
cyclin-dependent kinase
cytotoxicity
β-cyclodextrin
molecular docking
url https://www.mdpi.com/1422-0067/22/23/12675
work_keys_str_mv AT michalrouchal adamantanesubstitutedpurinesandtheirbcyclodextrincomplexessynthesisandbiologicalactivity
AT janarudolfova adamantanesubstitutedpurinesandtheirbcyclodextrincomplexessynthesisandbiologicalactivity
AT vladimirkrystof adamantanesubstitutedpurinesandtheirbcyclodextrincomplexessynthesisandbiologicalactivity
AT veronikavojackova adamantanesubstitutedpurinesandtheirbcyclodextrincomplexessynthesisandbiologicalactivity
AT richardcmelik adamantanesubstitutedpurinesandtheirbcyclodextrincomplexessynthesisandbiologicalactivity
AT robertvicha adamantanesubstitutedpurinesandtheirbcyclodextrincomplexessynthesisandbiologicalactivity